Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Niklas Plobeck is active.

Publication


Featured researches published by Niklas Plobeck.


Tetrahedron-asymmetry | 2002

Asymmetric synthesis of diarylmethylamines by diastereoselective addition of organometallic reagents to chiral N-tert-butanesulfinimines: switchover of diastereofacial selectivity

Niklas Plobeck; David Powell

Diastereoselective addition of organometallic reagents to chiral N-tert-butanesulfinimines gave alkylated adducts in high yields and diastereoselectivities. Cleavage of the chiral auxiliary under mildly acidic conditions gave diarylmethylamines in high yield. A reversal in the diastereoselectivity was observed by using either phenylmagnesium bromide in toluene or phenyllithium in THF. The use of the same chiral auxiliary thus allowed the synthesis of both enantiomers of a number of diarylmethylamines.


Bioorganic & Medicinal Chemistry Letters | 2012

Aminoimidazoles as Bace-1 Inhibitors: The Challenge to Achieve in Vivo Brain Efficacy

Britt-Marie Swahn; Jörg Holenz; Jacob Kihlström; Karin Kolmodin; Johan Lindström; Niklas Plobeck; Didier Rotticci; Fernando Sehgelmeble; M. Sundstrom; Stefan Berg; Johanna Fälting; Biljana Georgievska; Susanne Gustavsson; Jan Neelissen; Margareta Ek; Lise-Lotte Olsson

The evaluation of a series of bicyclic aminoimidazoles as potent BACE-1 inhibitors is described. The crystal structures of compounds 14 and 23 in complex with BACE-1 reveal hydrogen bond interactions with the protein important for achieving potent inhibition. The optimization of permeability and efflux properties of the compounds is discussed as well as the importance of these properties for attaining in vivo brain efficacy. Compound (R)-25 was selected for evaluation in vivo in wild type mice and 1.5h after oral co-administration of 300μmol/kg (R)-25 and efflux inhibitor GF120918 the brain Aβ40 level was reduced by 17% and the plasma Aβ40 level by 76%.


Journal of Medicinal Chemistry | 2000

New diarylmethylpiperazines as potent and selective nonpeptidic δ opioid receptor agonists with increased in vitro metabolic stability

Niklas Plobeck; Daniel Delorme; Zhongyong Wei; Hua Yang; Fei Zhou; Peter Schwarz; Lars Gawell; Hélène Gagnon; Benjamin Pelcman; Ralf Schmidt; Shi Yi Yue; Christopher Walpole; William J. Brown; Edward Zhou; Maryse Labarre; Kemal Payza; Stephane St-Onge; Augustus Kamassah; Pierre-Emmanuel Morin; Denis Projean; Julie Ducharme; Edward Roberts


Journal of Medicinal Chemistry | 2000

N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: A Novel, Exceptionally Selective, Potent δ Opioid Receptor Agonist with Oral Bioavailability and Its Analogues

Zhongyong Wei; William Brown; Bryan Takasaki; Niklas Plobeck; Daniel Delorme; Fei Zhou; Hua Yang; Paul Jones; Lars Gawell; Hélène Gagnon; Ralf Schmidt; Shi-Yi Yue; Chris Walpole; Kemal Payza; Stephane St-Onge; Maryse Labarre; Claude Godbout; Andrea Jakob; Joanne Butterworth; Augustus Kamassah; Pierre-Emmanuel Morin; Denis Projean; Julie Ducharme; Edward Roberts


Bioorganic & Medicinal Chemistry Letters | 2006

Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3.

Britt-Marie Swahn; Yafeng Xue; Erwan Arzel; Elisabet Kallin; Angelika Magnus; Niklas Plobeck; Jenny Viklund


Archive | 2007

Novel 2-amino-5, 5-diaryl-imidazol-4-ones

Stefan Berg; Jesper Hallberg; Katharina Högdin; Sofia Karlström; Annika Kers; Niklas Plobeck; Laszlo Rakos


Archive | 2003

Pyridine derivatives as jnk inhibitors and their use

Elisabeth Kallin; Niklas Plobeck; Britt-Marie Swahn; Arzel Erwan


Archive | 2003

4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders

William Brown; Andrew Griffin; Paul Jones; Daniel Page; Niklas Plobeck; Christopher Walpole


Archive | 2004

Novel pyridine derivatives as jnk specific inhibitors

Niklas Plobeck; Britt-Marie Swahn; Erwan Arzel


Archive | 2001

Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain

William Brown; Niklas Plobeck; Christopher Walpole

Collaboration


Dive into the Niklas Plobeck's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Edward Roberts

Scripps Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge